Trial intelligence / Profile preview

Treximet for Menstrual Migraine in Women with Dysmenorrhea

NCT00329459Phase 3Completed

Sponsor
GSK
Start
May 2006
Primary completion
Nov 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sumatriptan, Aprol in menstrual migraine, dysmenorrhea, sponsored by GSK. Started May 2006; status: completed.

02

Drugs

sumatriptanAprol
03

Conditions

menstrual migrainedysmenorrhea

Beyond the preview

Go deeper on NCT00329459.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00329459.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call